EGFR and glioblastoma: This study demonstrated that amlodipine exerts definite anti-GSC effects by inducing lysosome-dependent EGFR degradation via lipid raft-mediated endocytosis, thereby suppressing downstream pro-survival pathways of GSCs, which offers a promising therapeutic approach against development of glioblastoma.